Example: Heart Attack

Clinical Trials on Psoriasis

Total 1655 results

NCT04465838

Recruiting

Chinese Psoriasis Real World Evidence Research

Conditions: Psoriasis
NCT04459507

Not yet recruiting

A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan

Conditions: Palmoplantar Pustulosis
NCT04459780

Completed

Characterization and Functionality of Calcium Channels Cav1.4 of Th17 Lymphocytes in Human With Psoriasis

Conditions: Psoriasis
NCT04453137

Not yet recruiting

Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis

Conditions: Plaque Psoriasis
NCT04451720

Not yet recruiting

Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis

Conditions: Palmoplantar Pustulosis (PPP)
NCT04439526

Recruiting

A Study of Guselkumab in Naive or Bio-experienced Participants With Regional (Facial and Genital) Psoriasis

Conditions: Psoriasis
NCT04434885

Not yet recruiting

Axial Involvement in Psoriatic Arthritis Cohort

Conditions: Psoriatic Arthritis
NCT04435600

Not yet recruiting

A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms

Conditions: Psoriasis
NCT04435730

Not yet recruiting

Use of Serum M2BP and MSUS to Predict Arthritis in Psoriatic Patients

Conditions: Psoriasis
NCT04433442

Not yet recruiting

Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi Prefilled Syringe for Injection) in Adult Participants With Moderate to Severe Plaque Psoriasis

Conditions: Psoriasis
NCT04429776

Not yet recruiting

Tapering of Biologics in Inflammatory Arthritis Patients in Remission

Conditions: Rheumatoid Arthritis; Psoriatic Arthritis
NCT04426747

Recruiting

Impact of Barriers and Facilitators to Physical Activity in Patients With Inflammatory Arthritis

Conditions: Inflammatory Arthritis; Ankylosing Spondylitis; Rheumatoid Arthritis; Psoriatic Arthritis
NCT04428411

Not yet recruiting

Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).

Conditions: Plaque Psoriasis
NCT04428502

Not yet recruiting

Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)

Conditions: Psoriatic Arthritis
NCT04423471

Not yet recruiting

Neuroinflammation, Affective and Cognitive Symptoms in Major Depression and Psoriasis

Conditions: Psoriasis; Neuroinflammation; Major Depressive Disorder; Cognitive Symptom; Immunological Abnormality
NCT04418791

Not yet recruiting

Modified Intermittent Fasting in Psoriasis

Conditions: Psoriasis Vulgaris; Psoriasis
NCT04414605

Not yet recruiting

Oral Chinese Herbal Medicine Concurrent With Secukinumab for Severe Plaque Psoriasis

Conditions: Psoriasis
NCT04417114

Not yet recruiting

SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE

Conditions: Psoriasis; Psoriatic Arthritis; Cardiovascular Risk Factor
NCT04410237

Not yet recruiting

Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque Psoriasis With a Novel Needle-free Drug-delivery System

Conditions: Psoriasis
NCT04402554

Not yet recruiting

Survey of Cannabis Use in Patients With Chronic Inflammatory Arthritis

Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
NCT04402086

Recruiting

Rheumatology Patient Registry and Biorepository

Conditions: Rheumatic Diseases; Adult Onset Still Disease; Ankylosing Spondylitis; Psoriatic Arthritis; Reactive Arthritis; Antiphospholipid Syndrome; Systemic Lupus Erythematosus; Behcet Disease; Dermatomyositis; Polymyositis; Giant Cell Arteritis; Lyme Disease; Mixed Connective Tissue Disease; Polymyalgia Rheumatica; Rheumatoid Arthritis; Sarcoidosis; Systemic Sclerosis; Scleroderma; Sjogren's Syndrome; Undifferentiated Connective Tissue Diseases
NCT04399837

Recruiting

A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis

Conditions: Psoriasis
NCT04398732

Not yet recruiting

Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients

Conditions: Plaque Psoriasis
NCT04394936

Not yet recruiting

An Explorative Psoriasis Biomarker Study

Conditions: Psoriasis Vulgaris
NCT04380597

Active, not recruiting

Observational Study in Patients With Nail Psoriasis Treated With Enstilar® to Assess the Severity Change and the Quality of Life

Conditions: Nail Psoriasis
NCT04372277

Recruiting

Taltz in Combination With Enstilar for Psoriasis

Conditions: Psoriasis
NCT04371185

Not yet recruiting

Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects

Conditions: Psoriasis
NCT04367441

Recruiting

Randomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy Subjects

Conditions: Moderate to Severe Plaque Psoriasis
NCT04359394

Not yet recruiting

International Rare And Severe Psoriasis Expert Network

Conditions: Pustular Psoriasis (PP)
NCT04359628

Recruiting

How Does Patients' Overall Assessment of Their Health Vary Across and Within Different Disease Groups?

Conditions: Hip Disease; Heart Failure; Psoriasis; Fractures, Bone; Bipolar Disorder; Respiratory Failure; Knee Disease; Knee Injuries; Ankle Disease; Spinal Disease; Rheumatic Diseases; Osteoarthritis
NCT04347473

Recruiting

ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.

Conditions: Psoriasis
NCT04347798

Enrolling by invitation

IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT

Conditions: Covid-19 Infection; Rheumatoid Arthritis; Psoriatic Arthritis; Hydroxychloroquine
NCT04344574

Not yet recruiting

Serum Level of IL31,33 and 36 in Egyptian Paients With Psoriasis

Conditions: Psoriasis
NCT04345159

Active, not recruiting

Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease

Conditions: SARS-CoV-2; Systemic Lupus Erythematosus; Rheumatoid Arthritis; Sjogren's Syndrome; Psoriatic Arthritis
NCT04343586

Not yet recruiting

Blue Light Phototherapy

Conditions: Grover's Disease; Psoriasis Vulgaris
NCT04341233

Not yet recruiting

Enhanced Clinics for Patients Diagnosed With Ankylosing Spondylitis and Psoriatic Arthritis

Conditions: Spondylitis, Ankylosing; Psoriatic Arthritis
NCT04339595

Recruiting

Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis

Conditions: Plaque Psoriasis
NCT04340076

Not yet recruiting

Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis

Conditions: Psoriasis; Psoriasis Vulgaris
NCT04335747

Recruiting

COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases

Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Axial Spondyloarthritis; Systemic Lupus Erythematosus; Giant Cell Arteritis
NCT04334031

Not yet recruiting

Deployment o the Multidisciplinary Prospective Cohort Imminent

Conditions: Chronic Inflammatory Disease; Angioedema; Severe Asthma; Lupus; Atopic Dermatitis; Psoriatic Arthritis; Multiple Sclerosis; Systemic Sclerosis
NCT04325724

Not yet recruiting

Evaluation of the Role of Inflammatory and Structural Ultrasound Abnormalities by Explaining the Perspective of Patients With Psoriatic Arthritis

Conditions: Psoriatic Arthritis
NCT04324866

Not yet recruiting

Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy

Conditions: Coronavirus Infection
NCT04321291

Not yet recruiting

Information and Acceptability of Biosimilars

Conditions: Rheumatoid Arthritis; Spondyloarthritis; Psoriatic Arthritis
NCT04316533

Completed

Work Stress and Impact of Pruritus on Quality of Life

Conditions: Psoriasis
NCT04316585

Not yet recruiting

A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants

Conditions: Psoriasis
NCT04314531

Recruiting

Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

Conditions: Active Psoriatic Arthritis
NCT04314544

Recruiting

Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)

Conditions: Active Psoriatic Arthritis
NCT04308616

Not yet recruiting

Utility of Squamous Cell Carcinoma Antigen (SCCA) in Psoriasis

Conditions: Psoriasis
NCT04305327

Not yet recruiting

Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis

Conditions: Psoriasis
NCT04306315

Not yet recruiting

Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight

Conditions: Psoriasis Vulgaris